Scanu A M
Department of Medicine, Biochemistry and Molecular Biology, University of Chicago, Illinois 60637.
Am J Cardiol. 1995 Feb 23;75(6):58B-61B. doi: 10.1016/0002-9149(95)80013-i.
Using a technique that amplifies the DNA region coding for kringle 4-37 of human apolipoprotein(a) we have identified 2 mutations, trp72-->arg and met66-->thr. The former was only present in 2 of the 100 subjects studied, was associated with a lysine-binding defective lipoprotein(a) [Lp(a)], low plasma levels of Lp(a), and no evidence of atherosclerotic cardiovascular disease (ASCVD). The other mutation was present in about 40% of the subjects who had either normal or high plasma levels of Lp(a) and a personal and/or familial history of ASCVD. These studies show that human kringle 4-37 is mutable and that mutations in this kringle can affect the lysine-binding properties of apo(a) and, perhaps, the atherothrombogenic potential of Lp(a).
我们采用一种扩增人载脂蛋白(a)中编码kringle 4-37的DNA区域的技术,鉴定出了2种突变,即色氨酸72突变为精氨酸以及甲硫氨酸66突变为苏氨酸。前者仅在研究的100名受试者中的2名中出现,与赖氨酸结合缺陷型脂蛋白(a)[Lp(a)]、低血浆Lp(a)水平相关,且无动脉粥样硬化性心血管疾病(ASCVD)证据。另一种突变存在于约40%的Lp(a)血浆水平正常或升高且有ASCVD个人和/或家族病史的受试者中。这些研究表明,人kringle 4-37是可变的,该kringle中的突变可影响载脂蛋白(a)的赖氨酸结合特性,或许还会影响Lp(a)的动脉粥样硬化血栓形成潜能。